Skip to main content
. 2022 Oct 25;10:e14192. doi: 10.7717/peerj.14192

Table 1. Inhibitors applied in this study.

Target kinases Inhibitors
AKT MK-2206
PI3K LY294002
AMPK Dorsomorphin
CaMKII KN-62
PKA H-89
PKC Bisindolylmaleimide X

Notes.

Abbreviation

AKT
Protein kinase B
PI3K
Phosphatidylinositol-3-kinase
AMPK
AMP-activated protein kinase
CaMKII
Calcium-CaM-dependent protein kinase II
PKA
Protein kinase A
PKC
Protein kinase C